RESILIENCE GOVERNMENT SERVICES, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.ologybio.com
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT01492699
- Locations
- 🇺🇸
Sarkis Clinical Trials, Gainesville, Florida, United States
H5N1 Vaccine Study in Japanese Adults
- Conditions
- H5N1 Influenza
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 340
- Registration Number
- NCT01382329
- Locations
- 🇯🇵
Medical Co. LTA PS Clinic, Fukuoka-shi, Fukuoka-Ken, Japan
🇯🇵CPC Clinic, Medipolis Medical Research Institute, Kagoshima-shi, Kagoshima-Ken, Japan
🇯🇵Osaka Pharmacology Clinical Research Hospital, Osaka-shi, Osaka-Fu, Japan
Reverse Genetic H9N2 Influenza Vaccine Study in Adults
- Conditions
- Influenza
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 353
- Registration Number
- NCT01320696
- Locations
- 🇺🇸
Accelovance, Rockville, Maryland, United States
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
- Conditions
- Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
- Interventions
- Drug: GelVac™ nasal powder H5N1 influenza vaccine.Drug: Placebo
- First Posted Date
- 2010-12-10
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT01258062
- Locations
- 🇺🇸
Florida Research Network, LLC, Gainesville, Florida, United States
Ross River Virus (RRV) Vaccine Study
- Conditions
- Prophylaxis of Ross River Virus Infection
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 1968
- Registration Number
- NCT01242670
- Locations
- 🇦🇺
Holdsworth House, Byron Bay, New South Wales, Australia
🇦🇺Holdsworth House Medical Practice, Darlinghurst, New South Wales, Australia
🇦🇺St. Vincents Hospital, Darlinghurst, New South Wales, Australia
Yearly Strain Variation Study, 2010/2011
- Conditions
- Seasonal InfluenzaInfluenza
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT01157702
- Locations
- 🇦🇹
University Clinic for Clinical Pharmacology, General Hospital Vienna, Vienna, Austria
Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine
- Conditions
- Influenza
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 211
- Registration Number
- NCT01063088
- Locations
- 🇦🇹
Sanatorium Leech, Graz, Austria
🇧🇪ZU Gent, Centrum voor vaccinologie, Ghent, Belgium
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
- Conditions
- Influenza, Avian
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 684
- Registration Number
- NCT01052402
- Locations
- 🇦🇺
Princess Margaret Hospital for Children, Subiaco, Australia
🇫🇮Tampere University, Espoo Vaccine Research (Tampereen Yliopisto, Espoon Rokotetutkimus), Espoo, Finland
🇫🇮South Helsinki Vaccine Research Clinic (Etelä-Helsingin Rokotetutkimusklinikka), Helsinki, Finland
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
- Conditions
- InfluenzaPandemic Influenza
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT00976469
- Locations
- 🇩🇪
General Practice, Mönchengladbach, Germany
🇦🇹Allgemeines Krankenhaus (AKH) der Stadt Wien (General Hospital Vienna), Vienna, Austria
A/H1N1 Immunogenicity and Safety in Adults
- Conditions
- Pandemic InfluenzaInfluenza
- First Posted Date
- 2009-08-14
- Last Posted Date
- 2015-10-09
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 408
- Registration Number
- NCT00959465
- Locations
- 🇦🇹
Sanatorium Leech, Graz, Austria
🇦🇹ClinPharm International GmbH, Vienna, Austria
🇦🇹Medical University of Vienna, Institute for Specific Prophylaxis and Tropical Medicine, Vienna, Austria